Q1 2020 Holdings
Filed 2020-05-15 | 48 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $553.5M | 4,914,955 | 49.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $148.0M | 3,672,872 | 13.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $112.0M | 1,904,094 | 10.1% |
| Alector Inc(ALEC) | COM | 014442107 | $99.6M | 4,127,348 | 8.9% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $64.6M | 2,589,904 | 5.8% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $36.5M | 6,416,684 | 3.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $34.7M | 1,165,184 | 3.1% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $34.1M | 12,541,888 | 3.1% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $28.8M | 1,961,209 | 2.6% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $233.2K | 4,858,260 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $167.8K | 4,176,910 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $130.5K | 5,275,538 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $105.9K | 2,162,671 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $102.2K | 10,387,411 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $100.8K | 4,681,858 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $95.7K | 3,707,408 | 0.0% |
| Kala Pharmaceuticals Inc | COM | 483119103 | $95.6K | 10,874,613 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $82.5K | 5,422,312 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $79.8K | 3,161,214 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $77.9K | 4,524,961 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $72.9K | 7,775,207 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $71.1K | 7,272,714 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $68.9K | 2,531,445 | 0.0% |
| Retrophin Inc | COM | 761299106 | $60.8K | 4,166,453 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $57.0K | 10,364,658 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $55.2K | 982,723 | 0.0% |
| Verastem Inc | COM | 92337C104 | $49.1K | 18,604,651 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $47.1K | 1,379,988 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $41.0K | 548,000 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $39.5K | 3,240,534 | 0.0% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $26.0K | 3,518,998 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $25.7K | 6,361,446 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $25.6K | 1,119,963 | 0.0% |
| Imara Inc | COM | 45249V107 | $23.3K | 1,454,348 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $21.5K | 2,957,434 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $17.6K | 5,166,303 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $17.4K | 259,099 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $16.4K | 1,858,474 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $10.9K | 4,571,164 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $8.5K | 893,115 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $6.0K | 602,274 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $5.1K | 322,630 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $3.9K | 82,180 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $3.8K | 959,300 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $3.1K | 429,399 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $2.1K | 870,633 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.4K | 87,405 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $917 | 100,000 | 0.0% |